AGD vs CAF

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 5/9, indicating stable financial health, while the Altman Z-Score is unavailable, limiting distress risk assessment. The stock trades significantly below its Graham Number of $21.46 and intrinsic value of $51.92 at $12.50, suggesting deep value characteristics, supported by a low P/E of 7.10 versus sector average of 22.11. However, weak liquidity ratios, declining revenue, and lack of analyst coverage temper optimism, despite strong profitability margins and a high dividend yield of 10.46%. Technical trend is bearish, and insider sentiment is weak, creating a mixed but value-oriented profile.

The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. While the stock appears undervalued with a P/E of 4.44 and a growth-based intrinsic value of $29.05, these metrics are overshadowed by a bearish technical trend (10/100) and poor fundamental health. The disconnect between recent price gains and the underlying deterministic scores suggests a speculative rally rather than a fundamental recovery. Overall, the extreme weakness in the health scorecard outweighs the apparent value proposition.